ReShape Lifesciences, Inc.

The current price of RSLS is 0.1681 USD — it has decreased by 1.41% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange ReShape Lifesciences, Inc. stocks are traded under the ticker RSLS.

ReShape Lifesciences, Inc. is going to release the next earnings report on May 20, 2024. Keep track of upcoming events with our Earnings Calendar.

RSLS stock is 3.91% volatile and has beta coefficient of 1.77. Check out the list of the most volatile stocks — is ReShape Lifesciences, Inc. there?

RSLS earnings for the last quarter are −1.02 USD per share, whereas the estimation was −1.20 USD resulting in a 15.00% surprise. The estimated earnings for the next quarter are −0.18 USD per share. See more details about ReShape Lifesciences, Inc. earnings.

ReShape Lifesciences, Inc. revenue for the last quarter amounts to ‪2.16 M‬ USD despite the estimated figure of ‪2.40 M‬ USD. In the next quarter revenue is expected to reach ‪2.21 M‬ USD.

Yes, you can track ReShape Lifesciences, Inc. financials in yearly and quarterly reports right on TradingView.

RSLS net income for the last quarter is ‪−1.70 M‬ USD, while the quarter before that showed ‪−3.53 M‬ USD of net income which accounts for 51.95% change. Track more ReShape Lifesciences, Inc. financial stats to get the full picture.

Today ReShape Lifesciences, Inc. has the market capitalization of ‪3.94 M‬, it has increased by 3.34% over the last week.

No, RSLS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, RSLS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ReShape Lifesciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.

RSLS reached its all-time high on Oct 6, 2016 with the price of 23820.0000 USD, and its all-time low was 0.1414 USD and was reached on Feb 14, 2024.
See other stocks reaching their highest and lowest prices.

As of Apr 25, 2024, the company has 31.00 employees. See our rating of the largest employees — is ReShape Lifesciences, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ReShape Lifesciences, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ReShape Lifesciences, Inc. stock shows the sell signal. See more of ReShape Lifesciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ReShape Lifesciences, Inc. EBITDA is ‪−14.48 M‬ USD, and current EBITDA margin is −166.92%. See more stats in ReShape Lifesciences, Inc. financial statements.